🇺🇸 FDA
Patent

US 10227395

Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

granted A61KA61K2039/505A61P

Quick answer

US patent 10227395 (Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61P, A61P31/04